As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
XXVIII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2024)
The XXVIII EFMC International Symposium on Medicinal Chemistry is organised by the Medicinal Chemistry Division of Italian Chemical Society, on behalf of the European Federation for Medicinal chemistry and Chemical biology (EFMC). The symposium will take place in Rome, Italy from September 1-5, 2024. The EFMC is the main organisation for the European Medicinal Chemistry and Chemical Biology community, with 30 member societies and about 9.000 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery, and it traditionally attracts around 1.000 participants both from industry and academia. The scientific programme of EFMC-ISMC 2024 will furthermore cover a wide range of selected topics with parallel sessions split into three main themes:
❖Chemical Biology
❖Drug Discovery Pojects
❖Technologies
Medicilon is thrilled to exhibit in the conference. Dr. Paul van Stralen, VP of Strategic Collaborations EMEA at Medicilon, will be available throughout the conference. We invite you to visit us at Medicilon Booth #6 to explore our services and capabilities.
Date: September 1-5, 2024
Location: Rome, Italy
Medicilon Booth #6
With the rapid development of the global pharmaceutical market and the division of labor in the industry, the process of drug discovery and development is becoming increasingly refined. This makes specialized outsourcing an important strategic choice for pharmaceutical companies. In the early stages, companies often use FTE models for the synthesis of structural fragments and candidate compounds to accelerate the drug screening process. Medicilon provides comprehensive chemistry research services covering all stages of your project requirements, and we offer cooperation through both FFS and FTE models.